1332: Promising new treatments for pancreatic cancer and ALS
Pancreatic cancer is among the most deadly forms of cancer, and it can be difficult to catch early. But there’s some good news: Clinical trials of a new drug called daraxonrasib found that it doubled the survival time of patients with advanced pancreatic cancer. And some oncologists are calling it a game changer—not just for pancreatic cancer, but potentially other forms of cancer too. Ira talks with oncologist Zev Wainberg, who led a clinical trial for the drug. Plus, ALS is a degenerative disease that causes patients to lose their ability to walk, swallow and eventually to breathe. Now…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.